Insilico Medicine's Head of AI Platforms on Revolutionizing Drug DiscoveryInsilico Medicine's Head of AI Platforms on Revolutionizing Drug Discovery
December 14, 2022
.png?width=850&auto=webp&quality=95&format=jpg&disable=upscale)
Petrina Kamya, head of AI platforms at Insilico Medicine, talks to Andrew Brosnan, principal analyst in AI and Applied Intelligence at Omdia, to take a deep dive into the intricacies of AI-powered drug discovery.
Stay Ahead of the Curve
Get the latest news, insights and real-world applications from the AI Business newsletter
You May Also Like